Navigation Links
Intervention in infants with cystic fibrosis key to slowing progression
Date:12/4/2008

Early detection of lung disease in cystic fibrosis (CF), combined with aggressive treatment in infants, may be the key to controlling the progression of the disease, according to a recent study. New research shows that contrary to previous scientific opinion, progressive lung damage in CF patients can begin as early as infancy even though lung function shortly after diagnosis is normal.

"We might be able to stop some of the lung function reduction we're identifying in the first months of life," said Dr. Sarath Ranganathan, Ph.D., consultant respiratory physician at the Royal Children's Hospital in Melbourne, and lead author of the paper, which appeared in the second issue for December of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

"We don't know what's going to work, but we have to target those patients in the first six months of life if we're going to be effective," added Dr. Ranganathan.

In the Australian study, 68 infants with CF were compared to 49 infants without the disease. The children were between six weeks and 30 months of age. Forced expiratory volume (FEV) measurements were obtained for the children at baseline, and 16 of the children with CF were measured again one year later. FEV was equivalent for all children both with and without CF at baseline. But by six months of age, the mean FEV score was significantly lower in infants with CF compared to controlsand the deficit increased with each month of age. "This finding indicates that lung function declines sooner than previously thought," said Dr. Ranganathan.

The study also found that diminished lung function occurred even in the absence of clinical symptoms and irrespective of CF genotype. But, notably, infants measured soon after birth and within the first six months of life had normal lung function. Newborn screening for CF has been in existence in Australia for nearly 30 years, but was introduced only r
'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
2. Elseviers New Imaging Consult Features In-Depth, Authoritative Information For Diagnostic and Interventional Imaging and Procedures in a Single Online Resource
3. HealthMedia Announces Industrys First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features
4. Home-based diet and exercise intervention improves elderly cancer survivors physical function
5. Intervention program boosts survival in breast cancer patients
6. Psychological interventions associated with breast cancer survival
7. Rubenstein Public Relations to Launch National Campaign for The American Society of Interventional Pain Physicians
8. New model developed to estimate radiation skin doses during CT-guided interventional procedures
9. Interventions to Promote Breast-Feeding Succeed
10. The future of interventional cardiology presented at TCT 2008
11. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...27 With cold and flu season upon u...actices to control the spread of infections and av...ly to keep ourselves healthy, but to avoid transmi... RN, MS, CIC (certified in infection-control), nur...al health at Hospital for Special Surgery (HSS) in...
(Date:11/26/2009)... number of Americans living with diabetes will nea...o 44.1 million in 2034. Over the same period, spen...113 billion to $336 billion, even with no increase...t the University of Chicago report in the December... with diabetes covered by Medicare will rise from ...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...
(Date:11/26/2009)...esearch Triangle Dental (RTDental), a leading dent... announced the expansion of its services to includ...oug Macmillan. , Durha...ed to announce that Dr. Doug Macmillan, an experie...ditional advanced training seminar. RTDental&rsqu...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...SAN CARLOS, Calif., Nov. 6 Nektar,Therapeutics (N...ased 32%, or,$100.0 million, of its outstanding co...ollar, for a total purchase price of $47.8 million...argely complete," said Nektar,President and CEO Ho...
...MK-677 brought muscle mass, but long-term effects ...URSDAY, Nov. 6 (HealthDay News) -- An experimenta...owth hormone in seniors to youthful levels, a new ...d to significant improvements in their strength or...
...Third quarter revenues increase 65 percent versus ... at 4:30 p.m. Eastern Time Today, IRVINE, Calif.,...worldwide leader in intravascular temperature,mana...months ended September 30, 2008., Revenue for the...
...Quarterly Revenue Exceeds $10 Million Company Del...tember, BEDFORD, Mass., Nov. 6 Insulet Corporati...nology with its OmniPod(R),Insulin Management Syst...lion compared to,$3.8 million in the third quarter...
..., Atlanta, Ga. November 06, 2008 Down syndrome,...mpairment, occurs in approximately 1-in-700 births...cent of fetuses with Down syndrome are lost before...urrent knowledge of Down syndrome, identify inform...
...STEWARTVILLE, Minn., Nov. 6 Rochester Medical,Cor...g results for its fourth,quarter and year ended Se...les of $9,512,000 for the current quarter,compared...733,000 or $.06 per diluted share for the fourth q...
Other Medicine News:Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7Health News:Insulet Reports Third Quarter 2008 Results 2Health News:Insulet Reports Third Quarter 2008 Results 3Health News:Insulet Reports Third Quarter 2008 Results 4Health News:Insulet Reports Third Quarter 2008 Results 5Health News:Insulet Reports Third Quarter 2008 Results 6Health News:Insulet Reports Third Quarter 2008 Results 7Health News:Insulet Reports Third Quarter 2008 Results 8Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 2Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 3Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 4Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 5Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 6Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 7Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 8
(Date:11/25/2009)...5 ChemoCentryx, Inc., announced ...pany,s PROTECT-1 (the Prospective Randomized Oral ...aficet-EN(TM) (CCX282-B) in patients with moderate...fficacy with a favorable safety and tolerability p...al efficacy in the reduction of disease severity a...
(Date:11/24/2009)...ewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: EL...or aortic disorders, announced today that it has f...ngs in, the patent infringement lawsuit brought ag... was filed in the United States District Court in ...ed that the stay remain in effect while the United...
(Date:11/24/2009)...re-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nas...at the 21st Annual Piper Jaffray Healthcare Confer... (6:00 a.m. PST). The conference is being held at... President and Chief Executive Officer of Anadys, ...l development programs, ANA598 and ANA773. ,, T...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2BEA Opens the Doors to the World at G20 Summit 58230 1BEA Opens the Doors to the World at G20 Summit 58230 2BEA Opens the Doors to the World at G20 Summit 58230 3Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series 58228 1Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series 58228 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 1Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 4Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 5
...il 7, 2008 Genta,Incorporated (Nasdaq: GNTA ) an... (oblimersen sodium) Injection, the Company,s lead...l meeting of the American Association,for Cancer R...ego, CA from,April 12-16, 2008. The subject matter...the Company,s ongoing randomized Phase 3 trial of,...
...8 VIA,Pharmaceuticals (Nasdaq: VIAP ), a biotech...unds for the treatment of cardiovascular disease,a...nitoring Board (DSMB),for its VIA-2291 Phase 2 cli... safety for its current Phase 2 studies. The DSMB ...VIA-2291 and recommended VIA,continue its ongoing ...
Other Medicine Technology:Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 2Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4
...meter trial lens set has consistently been the mar...g only the highest level of quality throughout the...ns set continues to set the standard for excellenc...o the guidelines established by highly recognized ...
Non-Illuminated Trial Lens Set
Trial Lens Sets
L'Anthony's Desaturated 15 Hue Test
Medicine Products: